May 10th – CGIBD Research Seminar
Thursday, May 10 – “Malignancy risk of Anti-TNF-therapies in pediatric inflammatory bowel disease” given by Matthew Egberg, MD, MPH, MMSc, Assistant Professor of Pediatrics, Division of Pediatric GI, Hepatology & Nutrition, Center for Gastrointestinal Biology & Disease